Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Combination of primers and CRISPR sequence for detecting novel coronavirus gene, and application thereof

A primer sequence and gene technology, applied in the field of gene detection, can solve problems such as inconvenient operation and use, and achieve the effects of reducing the probability of missed detection, high sensitivity and easy operation.

Pending Publication Date: 2020-08-21
广州和盛医疗科技有限公司
View PDF3 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] On February 14, 2020, Professor Zhang Feng's team released the detailed operation process of using CRISPR / Cas13-based SHERLOCK technology to detect new coronaviruses. The essence is still single-tube detection and single-gene detection, and its sensitivity is achieved through a two-step method, that is, RPA amplification first, and on the basis of amplification, the amplification product needs to be added to the CrRNA / LwaCas13a reaction system to achieve. It is also inconvenient to operate and use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Combination of primers and CRISPR sequence for detecting novel coronavirus gene, and application thereof
  • Combination of primers and CRISPR sequence for detecting novel coronavirus gene, and application thereof
  • Combination of primers and CRISPR sequence for detecting novel coronavirus gene, and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Embodiment 1 synthetic RPA primer

[0019] RPA amplification primers were synthesized according to the sequence fragments of the selected ORF1ab and N genes, and the primer sequences are shown in Table 1 and Table 2 below. RPA primers were dissolved in RNase-free purified water to form a stock solution (24 μM), and stored at -20°C after aliquoting.

[0020] Table 1: RPA primer sequences for amplifying the ORF1ab gene fragment

[0021]

[0022] Table 2: RPA primer sequences for amplifying N gene fragments

[0023]

[0024]

Embodiment 2

[0025] Embodiment 2, synthetic CrRNA

[0026] Suzhou Synbio was commissioned to synthesize CrRNA, and the sequence information of CrRNAs is shown in Table 3. The synthesized CrRNA was dissolved into 10X stock solution (225nM) with RNase-free purified water, and stored at -20°C after aliquoting.

[0027] Table 3: Synthetic CrRNAs sequences

[0028]

Embodiment 3

[0029] Embodiment 3, the synthesis of reporter probe

[0030] The ssRNA reporter probe used by the Cas13 enzyme of the present invention: entrust Guangzhou Bolaisi to synthesize two ssRNA reporter probes. See Table 4 for sequence specific information. The synthesized ssRNA reporter probes were dissolved in RNase-free purified water to form a stock solution (1.25 μM), and stored at -20°C after aliquoting.

[0031] Table 4: Specific sequence information of reporter probes used by Cas13 protease

[0032]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides combination of primers and a CRISPR sequence for detecting novel coronavirus gene comprising two groups of primer pairs for RPA isothermal amplification for respectively detecting virus ORF1ab genes and N genes, and two crRNA sequences capable of respectively detecting RPA amplification products. The ORF1ab gene and the N gene can be detected at the same time through systemdetection, operation is easy and convenient, and each detection sample only needs to be detected through a single tube; the whole reaction process is carried out at the temperature of about 37 DEG C,a fine temperature control element and complex temperature change which are required by PCR amplification are not required, and the combination is suitable for a basic apartment to detect by using relatively cheap instant detection equipment; and the sensitivity reaches 10 copies / uL. Compared with a PCR technology, the advantages are that the speed is higher, an obvious detection signal can be obtained within 30 min, and whether the 2019-nCoV novel coronavirus nucleic acid result of a sample is positive or not can be rapidly judged.

Description

technical field [0001] The invention belongs to the technical field of genetic detection, and in particular relates to a detection system for detection of 2019-nCoV novel coronavirus ORFab1 gene and N gene and its application. Background technique [0002] Nucleic acid detection is the gold standard for non-invasive diagnosis of 2019-nCoV. Now 2019-nCoV nucleic acid detection generally adopts the real-time RT-PCR method. After the supply of detection kits increased, many cases found that the kits were negative. They have actually been infected with the new coronavirus, and the real-time PCR test takes a long time and is complicated to operate, making it difficult to meet the rapidly growing demand for investigation of suspected cases. Therefore, there is a demand for detection kits in terms of sensitivity, detection speed, price, and ease of operation. [0003] In recent years, a developed gene detection technology characterized by clustered regularly interspaced short pali...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/70C12Q1/6844C12N15/11C12R1/93
CPCC12Q1/701C12Q1/6844C12Q2521/107C12Q2521/327C12Q2525/161C12Q2563/107
Inventor 周海军吴家波
Owner 广州和盛医疗科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products